Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literature.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples